ARTICLE | Company News
Biotech Holdings, Laboratorios Saval S.A. sales and marketing update
October 4, 1999 7:00 AM UTC
Saval will exclusively distribute in Chile for seven years BIOHF's Diab II oral insulin receptor sensitizer to treat Type II diabetes. Saval will help prepare an application for Chilean marketing appr...